Expanding the diagnostic spectrum of malignant otitis externa: a case report of proteus infection in a non-immunosuppressed patient.

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Frontiers in Medicine Pub Date : 2025-07-02 eCollection Date: 2025-01-01 DOI:10.3389/fmed.2025.1577525
Fabián Darío Arias Rodríguez, Mercedes Larenas, Santiago Paredes, Guillermina Giuliano, Andrés López-Cortés, Juan S Izquierdo-Condoy
{"title":"Expanding the diagnostic spectrum of malignant otitis externa: a case report of proteus infection in a non-immunosuppressed patient.","authors":"Fabián Darío Arias Rodríguez, Mercedes Larenas, Santiago Paredes, Guillermina Giuliano, Andrés López-Cortés, Juan S Izquierdo-Condoy","doi":"10.3389/fmed.2025.1577525","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Malignant otitis externa (MOE) is a severe and potentially life-threatening infection of the external auditory canal, most frequently caused by <i>Pseudomonas aeruginosa</i>. Although typically seen in immunocompromised individuals-especially those with diabetes mellitus-up to 45% of cases have been reported in non-diabetic patients, highlighting the importance of recognizing atypical presentations. Rare pathogens, such as <i>Proteus mirabilis</i>, have been identified in only a few documented cases. Early diagnosis and prompt intervention are essential to prevent serious complications, including osteomyelitis and intracranial extension.</p><p><strong>Objectives: </strong>This report describes a really uncommon case of malignant otitis externa caused by <i>P. mirabilis</i> in a non-diabetic, immunocompetent patient.</p><p><strong>Case presentation: </strong>A 53-year-old male with no relevant medical history presented with a four-month history of left-sided otorrhea, otalgia, and preauricular pain. Examination and imaging revealed purulent discharge and bone erosion, suggestive of MOE. Empirical treatment with amoxicillin/clavulanic acid was ineffective. Culture identified <i>Proteus mirabilis</i>, resistant to multiple antibiotics but sensitive to piperacillin/tazobactam, which was administered with supportive care. After 17 days of intravenous therapy, the patient improved and was discharged on oral ciprofloxacin to complete a three-month course. Follow-up confirmed clinical resolution without recurrence.</p><p><strong>Conclusion: </strong>This case report highlights an exceptionally rare occurrence of MEO caused by <i>P. mirabilis</i> in an immunocompetent, non-diabetic patient. It emphasizes the need to consider uncommon pathogens and atypical clinical profiles in MOE. Early diagnosis, microbiological confirmation, and tailored antimicrobial therapy were critical for favorable outcomes.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1577525"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263653/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1577525","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Malignant otitis externa (MOE) is a severe and potentially life-threatening infection of the external auditory canal, most frequently caused by Pseudomonas aeruginosa. Although typically seen in immunocompromised individuals-especially those with diabetes mellitus-up to 45% of cases have been reported in non-diabetic patients, highlighting the importance of recognizing atypical presentations. Rare pathogens, such as Proteus mirabilis, have been identified in only a few documented cases. Early diagnosis and prompt intervention are essential to prevent serious complications, including osteomyelitis and intracranial extension.

Objectives: This report describes a really uncommon case of malignant otitis externa caused by P. mirabilis in a non-diabetic, immunocompetent patient.

Case presentation: A 53-year-old male with no relevant medical history presented with a four-month history of left-sided otorrhea, otalgia, and preauricular pain. Examination and imaging revealed purulent discharge and bone erosion, suggestive of MOE. Empirical treatment with amoxicillin/clavulanic acid was ineffective. Culture identified Proteus mirabilis, resistant to multiple antibiotics but sensitive to piperacillin/tazobactam, which was administered with supportive care. After 17 days of intravenous therapy, the patient improved and was discharged on oral ciprofloxacin to complete a three-month course. Follow-up confirmed clinical resolution without recurrence.

Conclusion: This case report highlights an exceptionally rare occurrence of MEO caused by P. mirabilis in an immunocompetent, non-diabetic patient. It emphasizes the need to consider uncommon pathogens and atypical clinical profiles in MOE. Early diagnosis, microbiological confirmation, and tailored antimicrobial therapy were critical for favorable outcomes.

扩大恶性外耳炎的诊断范围:一例非免疫抑制患者的变形杆菌感染报告。
恶性外耳炎(MOE)是一种严重且可能危及生命的外耳道感染,最常由铜绿假单胞菌引起。虽然通常见于免疫功能低下的个体,尤其是糖尿病患者,但高达45%的病例在非糖尿病患者中报道,强调了识别非典型表现的重要性。罕见的病原体,如变形杆菌,只在少数有记录的病例中被发现。早期诊断和及时干预对于预防严重并发症至关重要,包括骨髓炎和颅内扩张。目的:本报告描述了一个非常罕见的病例恶性外耳炎由奇异假单胞菌引起的非糖尿病,免疫功能正常的病人。病例介绍:53岁男性,无相关病史,左侧耳漏、耳痛、耳前疼痛4个月。检查和影像学显示脓性分泌物和骨侵蚀,提示MOE。阿莫西林/克拉维酸经验治疗无效。培养鉴定出奇异变形杆菌,对多种抗生素耐药,但对哌拉西林/他唑巴坦敏感,给予支持治疗。经17 天静脉治疗,患者病情好转,出院时口服环丙沙星,完成3个月疗程。随访证实临床消退无复发。结论:本病例报告强调了由奇异单胞杆菌引起的MEO在免疫功能正常的非糖尿病患者中的罕见发生。它强调在MOE中需要考虑不常见的病原体和非典型的临床特征。早期诊断、微生物学确认和量身定制的抗菌治疗是获得良好结果的关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信